SCHEMBL9724480

SCHEMBL9724480

CN(C)CCCCN1c2ccccc2Sc2ccc(Cl)cc21

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.93
CYP2D6 P10635 9/20 0.93
HTR1A P08908 6/20 0.93
LMNA P02545 6/20 0.93
TP53 P04637 6/20 0.93
CYP2C19 P33261 5/20 0.93
DRD2 P14416 5/20 0.93
MAPT P10636 5/20 0.93
CHRM2 P08172 5/20 0.93
ADRA2A P08913 5/20 0.93
CHRM1 P11229 5/20 0.93
DRD1 P21728 5/20 0.93
SLC6A2 P23975 5/20 0.93
SLC6A4 P31645 5/20 0.93
ADRA1A P35348 5/20 0.93
OPRM1 P35372 5/20 0.93
DRD3 P35462 5/20 0.93
KCNH2 Q12809 5/20 0.93
THPO P40225 5/20 0.93
MTOR P42345 5/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9724479 0.99 CYP1A2 (0.93) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL29358018 0.96 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL29367385 0.96 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL8321 0.96 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL23326209 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL5483904 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL41771 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL29351728 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL29714121 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53
Chlorpromazine SCHEMBL8503036 0.95 CYP1A2 (1.00) CYP1A2CYP2D6HTR1ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5104858-A Administering trans-flupenthiyol with doxorubicin; lack of antipsychotic activity reduces side effects YALE UNIVERSITY (US) 1992-04-14 US disclosed
EP-0361485-A2 A method of sensitizing multidrug resistant cells to antitumor agents YALE UNIVERSITY (US) 1990-04-04 EP disclosed